RLS Global ABFNSE RLS Global Stock Report

RLS Global AB develops and sells biochemical products and methods for treatment of diseases. The company is headquartered in Moelndal, Vastra Gotalands. The company went IPO on 2012-05-04. The company is primarily engaged in the development of biochemical products and methods for minimally invasive dentistry. The Company’s product portfolio includes Carisolv, a biochemical method for the removal of caries; Perisolv, product for the treatment of periodontitis; ChloraSolv, a treatment that cleanses and heals chronic wounds and Kindersolv, a caries treatment for children. The firm manufactures its products in the Sahlgrenska Science Park and sells them through distributors worldwide. The Company’s main shareholders are Rls Global Intressenter AB, Joki Invest AB, Zebra Holdings and Investments Limited.